A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy-Reference-Cited by-同舟云学术

A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy

Published:2023-07 Issue:7 Volume:13 Page:3027-3042
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Sun Luchen,Yang Nanfei,Chen Bing,Bei Yuncheng,Kang Zisheng,Zhang Can,Zhang Nan^ORCID,Xu Peipei,Yang Wei^ORCID,Wei Jia,Ke Jiangqiong,Sun Weijian,Li Xiaokun,Shen Pingping^ORCID

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Natural Science Foundation of Jiangsu Province

Natural Science Foundation of Zhejiang Province

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference53 articles.

1. Acute myeloid leukaemia;Short;Lancet,2018

2. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia;Lo-Coco;N Engl J Med,2013

3. Differentiation therapy revisited;de Thé;Nat Rev Cancer,2018

4. Hematopoietic stem cell transplantation for patients with AML in first complete remission;Cornelissen;Blood,2016

5. Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation;Middeke;Blood,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization strategies for mesenchymal stem cell-based analgesia therapy: a promising therapy for pain management;Stem Cell Research & Therapy;2024-07-18

2. A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation;Biochemical Pharmacology;2024-07

3. Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy;Frontiers in Immunology;2024-05-08